Levosimendan Key patent SPC and data exclusivity expiry 44 country coverage

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 144 pages

BMI View: Building on rapid expansion over the past five years, Latin America's pharmaceutical industry will record stronger medium-term growth, driven by the introduction of new products for the region's ageing population. However, Mexico looks set to suffer as persistent shortcomings in policy harmonisation ...

Industries: Generic Drug | Countries: Mexico

Biofarm SA (Romania) - Company Profile

Biofarm SA (Romania) - Company Profile

  • $ 64
  • Company report
  • by SeeNews - Research & Profiles
  • August 2014
  • 6 pages

Biofarm SA is the leading Romanian generic pharmaceuticals producer. The company meets Good Manufacturing Practice (GMP) requirements. Biofarm SA is listed on the first tier on the Bucharest stock exchange. Last update Jul 20,2014. Biofarm SA profile provides information on: - Company Name - Stock Symbol ...

Industries: Generic Drug | Countries: Romania

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Andreae-Noris Zahn AG SWOT Analysis report provides you a strategic ...

Industries: Generic Drug | Countries: Germany

Glenmark Generics Limited SWOT Analysis, Strategy, Revenues and Profits

Glenmark Generics Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: Germany, India, Argentina, Brazil, Canada, Slovenia, Poland, Austria

Zentiva NV (Symbol:BAAZEN) SWOT Analysis, Strategy, Revenues and Profits

Zentiva NV (Symbol:BAAZEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Zentiva NV SWOT Analysis report provides you a strategic analysis ...

Industries: Generic Drug | Countries: Netherlands, Europe, Czech Republic

Glenmark Generics Inc., USA SWOT Analysis, Strategy, Revenues and Profits

Glenmark Generics Inc., USA SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 19 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: United States

Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • August 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • August 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • August 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.